TISSUE THERAPIES LIMITED (TIS)
Developing biomedical technologies for wound healing and tissue and cell culture.On this page you will find:
| Delayed share price | ![]() |
Company details |
| Company announcements | Closing prices | |
| Price history chart | Dividends | |
| Exchange Traded Options | Warrants & Structured Products | |
| ASX CFDs |
Delayed share price
Prices are delayed by at least 20 minutes. Retrieving any price indicates your acceptance of the Conditions.
| Code | Last | % Chg | Bid | Offer | Open | High | Low | Vol |
|---|---|---|---|---|---|---|---|---|
| TIS | 0.205 | 0% | 0.205 | 0.210 | 0.210 | 0.215 | 0.205 | 425,173 |
TISSUE THERAPIES LIMITED details
Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.
| Issuer Code | TIS |
|---|---|
| Securities | |
| Official Listing Date | 19 March, 2004 |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences |
| Exempt Foreign? | No |
| Internet Address | http://www.tissuetherapies.com |
| Registered Office Address | Level 11, Central Plaza Two, 66 Eagle Street, BRISBANE, QLD, AUSTRALIA, 4000 |
| Head Office Telephone | (07) 3839 9938 |
| Head Office Fax | (07) 3839 1486 |
| Share Registry | LINK MARKET SERVICES LIMITED LEVEL 15, 324 QUEEN STREET, BRISBANE, QLD, AUSTRALIA, 4000 |
| Share Registry Telephone | (02) 8280 7454 |
| Directors / Senior Management |
|---|
|
Mr Roger Clarke (Chairman) Dr Steven Mercer (CEO, Director) Mr Gregory Baynton (Director) Mr Mel Bridges (Director) Dr Cherrell Hirst (Director) |
| Company Secretary |
Mr Drummond McKenzie |
|---|---|
| Principal Activities | Developing biomedical technologies for wound healing and tissue and cell culture. |
TISSUE THERAPIES LIMITED announcements
How are company announcements published on www.asx.com.au?
| Date | Price sens. |
Headline | Pages | |
|---|---|---|---|---|
| 02/09/2010 |
|
Exceptional VitroGro Clinical Results Continue | 3 | |
| 11/08/2010 | Directors Report and Full Year Statutory Accounts | 36 | ||
| 11/08/2010 |
|
Appendix 4E Preliminary Final Report | 2 | |
| 09/08/2010 |
|
VitroGro Patent Granted in Japan | 1 | |
| 23/07/2010 |
|
Appendix 4C for Quarter Ended 30 June 2010 | 5 | |
| 13/07/2010 |
|
Excellent Clinical Results and Manufacturing Complete | 2 | |
| 17/06/2010 |
|
More Exceptional Clinical Results for VitroGro | 3 | |
| 16/04/2010 |
|
Appendix 4C - quarterly | 5 | |
| 15/03/2010 | Investor Update March 2010 | 2 |
> search for past company announcements
Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF
announcements. Symptoms include slow downloads, blank documents, and small
white boxes appearing in the PDF. We recommend you download the latest version
of the free Adobe
Acrobat Reader. To check which version you have,
open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader
6.0'.
Closing prices
Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.
| Date | Last | % Change | High | Low | Vol * |
|---|---|---|---|---|---|
| 03 Sep 2010 | 0.205 | 5.13% | 0.205 | 0.190 | 504,500 |
| 02 Sep 2010 | 0.195 | 8.33% | 0.195 | 0.185 | 198,135 |
| 01 Sep 2010 | 0.180 | -5.26% | 0.190 | 0.180 | 53,000 |
| 31 Aug 2010 | 0.190 | 0% | 0.190 | 0.190 | 99,522 |
| 30 Aug 2010 | 0.190 | 2.7% | 0.190 | 0.185 | 106,548 |
* Volume of shares shown represents only those shares traded on ASX.
TISSUE THERAPIES LIMITED price history chart
ASX excludes all liability arising out of any inaccuracies in this chart, except where liability is made non-excludable by legislation. Chart values may be adjusted for changes in a company's capital structure or to link historical values that represent the company's primary equity security. Explanation of chart terms.

Dividends
How are dividends released on www.asx.com.au?
No dividends have been found for the security TIS. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.
Exchange Traded Options
No options are available over the security TIS
Warrants & Structured Products
No warrants & Structured Products are available over the security TIS
ASX CFDs
No Contracts For Differences are available over the security TIS


